About 100 reports

  • Gastrointestinal Drugs Market Forecast Growth
  • Gastrointestinal Drugs Market Trends And Strategies
  • Gastrointestinal Drug
  • World
  • Allergan plc
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited
  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, APPROVED GASTROINTESTINAL
  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, APPROVED GASTROINTESTINAL
  • Gastrointestinal Drug
  • World
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited
  • Zantac
  • Market trends

Offers a wide range of drugs and pharmaceuticals for the treatment of neuroscience and gastrointestinal diseases.

  • Gastrointestinal Drug
  • AstraZeneca PLC
  • Eisai Co., Ltd.
  • Johnson & Johnson
  • Takeda Pharmaceutical Company Limited
  • 07. Epidemiology of Gastrointestinal Disorders
  • GLOBAL GASTROINTESTINAL OTC DRUGS MARKET BY THERAPEUTIC CLASS OF DRUG
  • Gastrointestinal Drug
  • World
  • GlaxoSmithKline plc
  • Perrigo Company
  • Pfizer Inc.

The market is further broken down into the drugs to treat specific disorders within the gastrointestinal system, including the following: - Gastrointestinal tract disorders. - Gastrointestinal tract walls disorders. - Gastrointestinal motility disorders. -

  • Gastrointestinal Drug
  • OTC
  • World

Global Gastrointestinal Drugs Market : IGR Snapshots ##. ## Global Gastrointestinal Drugs Market key trends ##. ## Global Gastrointestinal Drugs Market by drug category ##. ## Global Gastrointestinal Drugs Market by route of administration ##. ## Global

  • Gastrointestinal Drug
  • OTC
  • World
  • Market Size
  • 02. List of Abbreviations
  • 17. Market Challenges

For instance, Amitiza causes nausea, dyspnea, mechanical gastrointestinal obstruction, and diarrhea.

  • Gastrointestinal Drug
  • AstraZeneca PLC
  • Sucampo Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited
  • Valeant Pharmaceuticals International, Inc.
  • 2. H2 RECEPTOR ANTAGONISTS
  • 3. DEVELOPING H2 RECEPTOR ANTAGONISTS

GASTROINTESTINAL ULCERS TREATMENT DRUGS ARE MAINLY PROTON PUMP INHIBITORS, H## RECEPTOR BLOCKERS, MUCOSAL PROTECTIVE AGENTS, ACID AGENTS.

  • Gastrointestinal Drug
  • China
  • Demand
  • Market Size
  • Trade
  • CHAPTER IV DIGESTIVE REMEDIES DRUGS PRODUCTION AND DEMAND

THE INCIDENCE OF GASTROINTESTINAL DISEASES AROUND THE WORLD WAS ABOUT ##% OF POPULATION.

  • Gastrointestinal Drug
  • China
  • Demand
  • Market Size
  • Xian-Janssen Pharmaceutical Ltd.

GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide.

  • Gastrointestinal Drug
  • OTC
  • World
  • Market Size
  • 10.2 ABBREVIATIONS
  • 2.1 CATALYST

The usage of opioids and their adverse effects in gastrointestinal practice: a review.

  • Gastrointestinal Drug
  • Europe
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Progenics Pharmaceuticals, Inc.
  • SAFETY OF LOTRONEX - MOST FREQUENTLY REPORTED ADVERSE EVENTS
  • Disease Management

HOUSEHOLDER SURVEY OF FUNCTIONAL GASTROINTESTINAL DISORDERS.

  • Gastrointestinal Drug
  • Actavis plc
  • Almirall, S.A.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Gastrointestinal infection
  • Clinical Trials by E7 Countries: Proportion of Diarrhea to Gastrointestinal Clinical...
  • Drug Discovery And Development
  • Gastrointestinal Drug
  • United States
  • World
  • Furiex Pharmaceuticals, Inc.

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics.

  • Gastrointestinal Drug
  • China
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Tianjin Pharmaceutical Co., Ltd.

Some of the prominent trends that the market is witnessing include occurrence of serious health issues with excessive usage of saline laxative, growing incidence of gastrointestinal diseases, recent technological developments of Saline Laxative and growth opportunities/ investment oppor

  • Gastrointestinal Drug
  • Asia
  • Europe
  • World
  • Forecast

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics. - Haitian International Trading Co., Ltd Principle operation: import and export activities, international business development, purchasing and handling import of pa

  • Gastrointestinal Drug
  • China
  • Demand
  • AstraZeneca China Inc.
  • Eisai Co., Ltd.
  • Other Adverse Events
  • Drug Details

Mechanism of Action Vonoprazan fumarate (Takecab) is a novel anti-secretory drug, acts as gastrointestinal Protective Agent, formulated as tablets for the oral route of administration.

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Clinical Trials by G7 Countries: Proportion of Reflux Esophagitis (Gastroesophageal Reflux...
  • PROPORTION OF REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) TO GASTROINTESTINAL...
  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • COMPETITIVE LANDSCAPE
  • TRENDS

This expectancy is related to the shopping behaviour of many consumers regarding products affecting their gastrointestinal health.

  • Gastrointestinal Drug
  • OTC
  • Germany
  • Demand
  • Boehringer Ingelheim GmbH
  • Passport 2
  • Passport 4

Irritable Bowel Syndrome or IBS is a common chronic gastrointestinal disorder.

  • Gastrointestinal Drug
  • OTC
  • Canada
  • Demand
  • Bayer AG

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics.

  • Gastrointestinal Drug
  • China
  • AstraZeneca PLC
  • Nanjing Aosaikang Medicinal Group
  • Xian-Janssen Pharmaceutical Ltd.
  • COMPETITIVE LANDSCAPE
  • Various Lifestyle Trends Affect Consumer Health in 2016

Russian consumers are not usually very open to experimenting when it comes to their gastrointestinal health.

  • Gastrointestinal Drug
  • OTC
  • Russian Federation
  • Demand
  • TRENDS
  • Passport 20

Stress can both induce and worsen gastrointestinal upset, and is linked to nausea, indigestion, heartburn and the development of ulcers.

  • Gastrointestinal Drug
  • United States
  • Demand
  • Bayer AG
  • Walgreen Co.
  • TRENDS

gastrointestinal problems supports growth Antacids sees strongest current value growth of ##% in 2016 Carlo Erba and Sanofi-Aventis lead fragmented sales with ##% value share each in 2016 ##% value CAGR at constant 2016 prices expected for forecast period to reach €## million in 2021 A growin

  • Gastrointestinal Drug
  • OTC
  • Italy
  • Demand
  • Patient Details
  • Drug Details

Mechanism of Action Lafutidine (Protecadin, Stogar) is an anti-ulcer drug and a gastrointestinal agent.

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Gastrointestinal Drugs
  • Six: Gastrointestinal Drugs
  • Gastrointestinal Drug
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics. - Haitian International Trading Co., Ltd Principle operation: import and export activities, international business development, purchasing and handling import of pa

  • Gastrointestinal Drug
  • China
  • AstraZeneca China Inc.
  • Eisai Co., Ltd.
  • Nanjing Aosaikang Medicinal Group
  • COMPETITIVE LANDSCAPE
  • PROSPECTS

Lack of exercise and sedentary lifestyles have caused not only weight gain but also gastrointestinal problems.

  • Allergy Drug
  • Gastrointestinal Drug
  • Vitamin
  • Russian Federation
  • Demand
  • Other gastrointestinal disease, total (000s)
  • IBS patients with gastroenteritis, total (000s)
  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Europe
  • Italy
  • Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, E7 Countries...
  • Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, G7 Countries...
  • Drug Discovery And Development
  • Gastrointestinal Drug
  • United States
  • World
  • Salix Pharmaceuticals, Ltd.